ONI
Patrick Finn is an accomplished executive with extensive experience in the life sciences industry. Currently serving as President and Chief Operating Officer at Twist Bioscience, as well as Independent Director and Chairman at ONI, Finn has a robust background in commercializing nucleic acid synthesis platforms and has held various leadership roles. Previous positions include Chief Commercial Officer and SVP of Commercial Operations at Twist Bioscience, Vice President of Sales and Marketing at Enzymatics, and Director of Business Development at Agilent Technologies. In addition to roles on scientific advisory boards and boards of directors at several biotech companies, Finn has significant expertise in research and development, particularly in nucleic acid purification and sequencing technologies. Finn holds a Ph.D. in Chemistry from the University of Southampton and a Bachelor's Degree in Chemistry from Heriot-Watt University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
ONI
7 followers
ONI is a pioneer of next generation super-resolution microscopy, making this advanced technology accessible to new generations of researchers. The Nanoimager, the world's first benchtop sized super-resolution microscope, delivers a step change in usability and precision. The microscope offers easy access to a range of super-resolution techniques including dSTORM and PALM, as well as smFRET, single-particle tracking and confocal. The company's achievements have been recognised by FastTrack100 who named ONI on their 2018 list of 10 Disruptors to Watch and ONI won Best Business Start-up at the 2018 IOP Awards. More and more life science researchers and pharma companies are taking an interest in ONI and it now has customers using its products in leading laboratories across the globe, including the Universities of Oxford, Cambridge and Harvard. ONI has a restless enthusiasm to make the world a better place. Our ambition is to bring super-resolution fluorescence imaging to a new community of researchers and we are removing barriers to make science more effective, accessible and affordable. We have a vision for making high tech science available to anyone, anywhere, from the research bench to your doctor’s office.